Well, given that last year I managed to lose more money than I earned in my portfolio, this year has a lot to do to make up. Rather doggedly, I am sticking with most of my picks as they have been heavily oversold and still have some good potential.
Above we can see the last month's price action on this year's portfolio. GKP, EMED and Xcite are my main holdings with the other being materially smaller. I have swapped CAZA for Ithaca as the takeover of Ithaca I expect to be in the 220-240p range and I bought at 170p.
So Xtract apart this year has been all good so far, with GKP up over 50% which is massive for my portfolio and is now 1000% ahead of the original 2009 purchase at 28p. So it proves the strategy of buying high risk and waiting can work. The busted ones after all only ever lose 90% - My guesstimate average is that I hit about 1 in 4 so for every 100 pounds I am losing 70 and gaining 150 plus - so enough for me to persevere with.
Rather sadly, EMED still appears a quarter away from getting approval as does Xcite, so i am happy with any gains there and in fact expect a fall back over the next quarter. Over all YTD am up 33% - worrying echoes of last year where the same thign happened until March and then a huge bust....